行情

CPHI

CPHI

中国医药控股
AMEX

实时行情|Nasdaq Last Sale

0.8873
-0.0346
-3.75%
盘前: 0.9149 +0.0276 +3.11% 09:05 03/01 EST
开盘
0.9000
昨收
0.9219
最高
0.9200
最低
0.8401
成交量
39
成交额
--
52周最高
1.400
52周最低
0.3200
市值
3,866.81万
市盈率(TTM)
-1.8951
分时
5日
1月
3月
1年
5年
新闻
财报
公告
公司事件
分析
简况
惠普森医药(CPHI.US)Q3营收240万美元,净亏损100万美元
智通财经网 · 2020/11/14 23:58
惠普森医药(CPHI.US)Q3营收240万美元,净亏损100万美元
智通财经网 · 2020/11/14 23:58
惠普森医药(CPHI.US)Q3营收240万美元,净亏损100万美元
智通财经网 · 2020/11/14 23:58
惠普森医药(CPHI.US)Q3营收240万美元,净亏损100万美元
智通财经网 · 2020/11/14 23:58
惠普森医药(CPHI.US)Q3营收240万美元,净亏损100万美元
智通财经网 · 2020/11/14 23:58
China Pharma Holding Q3 EPS $(0.02), Same YoY, Sales $2.40M Up From $2.38M YoY
China Pharma Holding (AMEX:CPHI) reported quarterly losses of $(0.02) per share. This is unchanged from the same period last year. The company reported $2.40 million in sales this quarter. This is a 1.01 percent
Benzinga · 2020/11/13 21:14
惠普森医药(CPHI.US)盘前涨超22% 公司生产口罩已被列入白名单
智通财经 · 2020/10/21 14:09
惠普森医药(CPHI.US)盘前涨超22% 公司生产口罩已被列入白名单
智通财经 · 2020/10/21 14:09
更多
财务预测
每股收益每股净资产每股现金流
暂无数据
利润表更多
净利润营业总收入营业利润
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流投资现金流筹资现金流
经营现金流(美元)
同比(%)
了解CPHI最新的财务预测,通过CPHI每股收益,每股净资产,每股现金流等数据分析中国医药控股近期的经营情况,然后做出明智的投资选择。
暂无数据
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+0.06%
制药与医学研究
-0.68%
高管信息
Chairman/President/Chief Executive Officer/Chief Financial Officer/Director
Zhilin Li
Director
Heung Tsui
Independent Director
Gene Bennett
Independent Director
Baowen Dong
Independent Director
Yingwen Zhang
  • 分红
  • 拆股
  • 内部人交易
暂无数据
CPHI 简况
China Pharma Holdings, Inc. is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson) in the People's Republic of China (PRC). It is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC. It manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. Its pharmaceutical products are sold on a prescription basis and are approved by the China Food and Drug Administration (the CFDA). The Company manufactured over 20 pharmaceutical products for various diseases and medical indications. It offers products for Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases and Others.

微牛提供China Pharma Holdings, Inc.(AMEX-CPHI)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CPHI股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CPHI股票基本功能。